Support: +91-22-61011756 / help@projectstoday.com
Help
1. Boolean Searches :

i. AND - Shows results where both terms on either side of the 'AND' operator are present. 'AND' must be in upper case. For example search term - delhi AND metro result - It will return records in which 'delhi' as well as 'metro' both are present.

ii. OR - Shows results where either term (or both terms) is present. 'OR' must be in upper case. For example search term - delhi OR metro result - It will return records in which either 'delhi' or 'metro' or both are present

2. Proximity Searches

A proximity search looks for terms that are within a specific distance from one another. For example, search term - 'delhi metro'~10 result - It will search for records where 'delhi' and 'metro' are found within 10 words of each other

3. Phrase searches

You can search phrases using double quotes. for e.g. 'delhi metro' result - It will return records where 'delhi metro' phrase is found.

Dishman Group to invest USD 50 million in drug manufacturing facility

Thursday, 21 Oct 2021
Share this on :
As part of its expansion plans, Gujarat-headquartered drug developer Dishman Carbogen Amcis (DCAL) will invest USD 50 million in France to set up a new facility for manufacturing formulated products, mainly in the form of parenterals.
 
The new facility will begin commercial production from January 2023 with two manufacturing lines.
 
The company is expanding in France, where it already has a small facility. Now, it is setting up a greenfield (fresh) project close to the existing plant with an investment of USD 50 million for manufacturing formulated products, mainly parenterals or injectables.
 
The new plant is around three km away from the existing facility. Eventually, it may shift the work of the small plant to this new facility, having the capacity for four manufacturing lines. The company will be starting with two of them and the other two will be for future purpose. The commencement of commercial production is planned to start commercial from January 2023.
 
The company is already working on the 'corrective action plan' which it had submitted to the European drug authority to resolve the observations.
 
Post Your Comments
 
 
   
 

 

 
  
Sign up to start your trial access

Are you...



REGISTER AND GET STARTER KIT ABSOLUTELY FREE!

Free access to Project News and Analysis

Project and Tender Alert in your mailbox

Explore the largest Database on Projects for free

Be part of Online Projects Community

User login
Start Exploring

Subscribe to any of our premium plans to

Access to complete information on 43000+ projects

Use our Notification service for instant update on projects and tenders

Closely monitor your opportunities with "WORKSPACE"

Use our online platform for promotions of your products and services